Genomic Cancer Testing Market is Estimated To Witness High Growth Owing To Technological Advancements and Increasing Incidence of Cancer
The Genomic Cancer Testing Market is estimated to be valued at US$16.15 billion in 2023 and is expected to exhibit a CAGR of 16.1% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.